FDA finalizes electronic postmarketing safety reporting guidance

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesCombination products/companion diagnosticsNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy